The silent risks of blood transfusion

Purpose of review Clinical research has identified blood transfusion as an independent risk factor for immediate and long-term adverse outcomes, including an increased risk of death, myocardial infarction, stroke, renal failure, infection and malignancy. New findings have called into question the traditional assumptions clinicians utilize in evaluating the risks and benefits of blood transfusion. Appreciation of newly recognized risks is important for conserving scarce resources and optimizing patient outcomes. Recent findings Recent clinical outcomes research has examined the impact of blood transfusion on critically ill patients, trauma patients, patients undergoing cardiac surgery, patients experiencing acute coronary syndromes, oncology patients and others. These studies provide additional evidence of adverse outcomes associated with blood transfusion in a wide variety of clinical contexts. Summary The benefits of blood transfusion have never been conclusively demonstrated, but evidence of transfusion-related harm continues to accumulate. Given the transfusion triggers that currently predominate in clinical practice it appears that clinical outcomes could improve significantly with more widespread adoption of restrictive transfusion strategies.

[1]  H. Krumholz,et al.  Blood transfusion in elderly patients with acute myocardial infarction. , 2001, The New England journal of medicine.

[2]  Robert W. Taylor,et al.  Red blood cell transfusions and nosocomial infections in critically ill patients* , 2006, Critical care medicine.

[3]  Thomas M Scalea,et al.  Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. , 2003, The Journal of trauma.

[4]  A. Voors,et al.  Hemoglobin levels and 30-day mortality in patients after myocardial infarction. , 2005, International journal of cardiology.

[5]  B. Spiess.  Red Cell Transfusions and Guidelines: A Work in Progress , 2007, Hematology/Oncology Clinics of North America.

[6]  Ross Gagliano,et al.  Review of , 2006, UBIQ.

[7]  A. Shorr,et al.  Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study , 2007, Critical care.

[8]  J. Gardin,et al.  Blood Transfusion and In‐hospital Outcomes in Anemic Patients with Myocardial Infarction Undergoing Percutaneous Coronary Intervention , 2007, Clinical cardiology.

[9]  Sunil V. Rao,et al.  The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. , 2005, Journal of the American College of Cardiology.

[10]  Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery , 2007 .

[11]  J. Twisk,et al.  Red blood cell transfusion in critically ill children is independently associated with increased mortality , 2007, Intensive Care Medicine.

[12]  M. Keegan,et al.  Toward the prevention of acute lung injury: Protocol-guided limitation of large tidal volume ventilation and inappropriate transfusion* , 2007, Critical care medicine.

[13]  Chris A Rogers,et al.  Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery , 2007, Circulation.

[14]  Sibu P Saha,et al.  Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. , 2007, The Annals of thoracic surgery.

[15]  Liang Li,et al.  Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting* , 2006, Critical care medicine.

[16]  R. Groom,et al.  Intraoperative Red Blood Cell Transfusion During Coronary Artery Bypass Graft Surgery Increases the Risk of Postoperative Low-Output Heart Failure , 2006, Circulation.

[17]  William Wijns,et al.  [Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes]. , 2007, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[18]  J. Cerhan,et al.  Blood transfusion, anesthesia, surgery and risk of non‐Hodgkin lymphoma in a population‐based case–control study , 2008, International journal of cancer.

[19]  Angelo Branzi,et al.  Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: the task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology. , 2007, European heart journal.

[20]  G. Wells,et al.  A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. , 1999, The New England journal of medicine.

[21]  I. C. Tudor,et al.  Impact of Preoperative Anemia on Outcome in Patients Undergoing Coronary Artery Bypass Graft Surgery , 2007, Circulation.

[22]  D. Ngaage,et al.  Early neurological complications after coronary artery bypass grafting and valve surgery in octogenarians. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[23]  W. Markiewicz,et al.  Changes in haemoglobin levels during hospital course and long-term outcome after acute myocardial infarction. , 2007, European heart journal.

[24]  F. Marincola,et al.  Transfusion-transmitted infections , 1991, Journal of Translational Medicine.

[25]  M. Ranucci,et al.  Body size, gender, and transfusions as determinants of outcome after coronary operations. , 2008, The Annals of thoracic surgery.

[26]  D. Chinkes,et al.  Blood transfusions are associated with increased risk for development of sepsis in severely burned pediatric patients* , 2007, Critical care medicine.

[27]  T. Mihaljevic,et al.  Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. , 2006, The Annals of thoracic surgery.

[28]  M. Levy,et al.  The CRIT Study: Anemia and blood transfusion in the critically ill—Current clinical practice in the United States* , 2004, Critical care medicine.

[29]  R. Habib,et al.  Effect of blood transfusion on long-term survival after cardiac operation. , 2002, The Annals of thoracic surgery.

[30]  R. Groom,et al.  Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. , 2001, The Annals of thoracic surgery.

[31]  M. Zahid,et al.  Impact of blood transfusions in patients presenting with anemia and suspected acute coronary syndrome. , 2007, The American journal of cardiology.

[32]  J. Collet,et al.  Transfusion strategies for patients in pediatric intensive care units. , 2007, The New England journal of medicine.

[33]  G. Hicks,et al.  Increased risk of infection and mortality in women after cardiac surgery related to allogeneic blood transfusion. , 2007, Journal of women's health.

[34]  A. Charles,et al.  Blood Transfusion is an Independent Predictor of Mortality after Blunt Trauma , 2007, The American surgeon.

[35]  J. Marshall,et al.  Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? , 2001, Critical care medicine.

[36]  J. Doyle,et al.  Anemia, transfusions and hospital outcomes among critically ill patients on prolonged acute mechanical ventilation: a retrospective cohort study , 2008, Critical care.

[37]  R. Winslow,et al.  Red cell age and loss of function: advance or SNO‐job? , 2008, Transfusion.

[38]  R. Hickey,et al.  Anemia and blood transfusion in the critically ill: a decade without change. , 2004, Critical care medicine.

[39]  T. Mihaljevic,et al.  Duration of red-cell storage and complications after cardiac surgery. , 2008, The New England journal of medicine.

[40]  C. Eby,et al.  A review of transfusion risks and optimal management of perioperative bleeding with cardiac surgery , 2008, Transfusion.

[41]  M. Mathru,et al.  Myocardial metabolism and adaptation during extreme hemodilution in humans after coronary revascularization , 1992, Critical care medicine.

[42]  S. Solomon,et al.  Clinical Correlates and Consequences of Anemia in a Broad Spectrum of Patients With Heart Failure: Results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program , 2006, Circulation.

[43]  Sunil V. Rao,et al.  Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. , 2004, JAMA.

[44]  P. Friedmann,et al.  Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. , 2007, JAMA.

[45]  S. Kitano,et al.  Prognosis and postoperative lymphocyte count in patients with hepatocellular carcinoma who received intraoperative allogenic blood transfusion: a retrospective study. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[46]  J. Stamler,et al.  S-nitrosohemoglobin deficiency: A mechanism for loss of physiological activity in banked blood , 2007, Proceedings of the National Academy of Sciences.

[47]  D. Wijeysundera,et al.  Risk Associated With Preoperative Anemia in Cardiac Surgery: A Multicenter Cohort Study , 2008, Circulation.